DJIA 16,912.29 122.10 0.73%
NASDAQ 4,791.15 42.79 0.90%
S&P 500 1,995.83 15.91 0.80%
market minute promo

Celgene (NASDAQ: CELG)

116.99 4.80 (4.28%)

REAL-TIME: Last trade at

Extended Hours: $116.98 -$0.01 (-0.01%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CELG $116.99 4.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.81
Previous Close $112.19
Daily Range $110.88 - $118.50
52-Week Range $83.16 - $140.72
Market Cap $92.5B
P/E Ratio 42.50
Dividend (Yield) $0.00 (0.0%)
Volume 8,114,622
Average Daily Volume 6,282,951
Current FY EPS $4.36




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

Biotech's Bloodbath Is Ridiculous; Here's Why

Biotech stocks have been getting pummeled in the last two months. A deeper look at the root cause of this sell-off, though, shows that it's probably unwarranted, making now a great time to buy these stocks on the cheap.

Stock Market News for October 07, 2015

Cramer -- Take Cisco Over Juniper and Buy Celgene, Too

XLV, ABBV, CELG, ESRX: Large Inflows Detected at ETF

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

The Biotech Infection - Cramer's Mad Money (10/6/15)

Biotech Bears Spark Good Vibes For These ETFs

Top 2 Trade Alert Ideas October 2: Geron Catalysts, Endocyte's Valuation, Drug Pricing

Who Wins and Loses with the TPP?

'Fast Money' Recap: Have Markets Risen Too Far Too Fast?

See More CELG News...

CELG's Top Competitors

CELG $116.99 (4.28%)
Current stock: CELG
GILD $100.27 (2.80%)
Current stock: GILD
BIIB $279.25 (1.18%)
Current stock: BIIB
AMGN $148.22 (4.96%)
Current stock: AMGN